Pharmacokinetic investigation of branched oligohexamethyleneguanidine hydrochloride in a liquid composition for the treatment of stomatitis and gingivitis-Reference-Cited by-同舟云学术

Pharmacokinetic investigation of branched oligohexamethyleneguanidine hydrochloride in a liquid composition for the treatment of stomatitis and gingivitis

Published:2021-11-02 Issue:11 Volume:47 Page:1764-1774
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Beliakov S. V.¹^ORCID,Shatalov D. O.¹^ORCID,Aldobaev V. N.²^ORCID,Ivanov I. S.¹^ORCID,Aydakova A. V.¹^ORCID,Akhmedova D. A.¹³^ORCID,Kedik S. A.¹^ORCID

Affiliation:

1. Institute of Fine Chemical Technologies Named After M. V. Lomonosov, MIREA–Russian Technological University, Moscow, Russia

2. State Federal Enterprise for Science ‘Research Center for Toxicity and Hygienic Regulation of Biopreparations’ at Federal Medico Biological Agency, The Ministry of Health of the Russian Federation, Serpukhov, Russia

3. JSC ‘Institute of Pharmaceutical Technologies’, Moscow, Russia

Funder

Ministry of Science and Higher Education of the Russian Federation

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2022.2058012

Reference28 articles.

1. A need for new generation antibiotics against MRSA resistant bacteria

2. Structure and molecular-weight characteristics of oligo(hexamethyleneguanidine) hydrochlorides

3. Kedik SA, inventor, assignee; Sedishev IP, inventor, Panov AV. inventor. Branched oligomers on the basis of a guanidine derivative and disinfecting agent containing said oligomers (alternatives). Russian Federation patent RU WO/2012/082009; 2012.

4. Antimicrobial activity of branched oligo(hexamethyleneguanidine) hydrochloride on oral pathogens